RBP2 and gastric cancer: For the first time, we demonstrate that the TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit may be a novel mechanism for EMT and GC metastasis and targeting RBP2 expression may have therapeutic advantage for the prevention of tumor metastasis.